What 2026 holds for biotech and Quality - with Jon Voss and Ed Armstrong

What 2026 holds for biotech and Quality - with Jon Voss and Ed Armstrong

In today’s episode, Hemish was joined by Ed Armstrong and Jon Voss, two Quality leaders who’ve both worked across early-stage, clinical, and complex biotech environments.

Ed and Jon share what they’re seeing on the ground - from funding pressure and modality shifts, to how regulators are engaging, and where Quality leaders are gaining (or losing) influence.

They talk about the following:

  • The current state of pharma and biotech, and whether the market has really bottomed out
  • Which modalities and parts of the market feel resilient, and which are still struggling
  • How FDA leadership changes are (and aren’t) showing up in day-to-day work
  • The shift toward written-only FDA interactions and what that means for sponsor–agency relationships
  • Whether regulators are prioritising speed or risk, and how that tension plays out
  • Where AI and digital tools are genuinely adding value today, versus where there’s still a lot of noise
  • How Quality has evolved from “policing” to partnership over the last 20 years
  • Why pragmatic, phase-appropriate Quality systems matter more than perfection
  • Burnout in senior Quality leaders and the risk of doing too much with too few people
  • What separates Quality leaders who are listened to from those who are merely tolerated
  • What the strongest Quality teams will be doing differently by the end of 2026

Ed and Jon bring a huge amount of perspective, humility, and real-world insight to this discussion. This is a conversation for anyone leading Quality through uncertainty and trying to balance patient safety, speed, and sustainability.

Hope everyone enjoys the show!

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(82)

Geetu Abbi on When to Build a Digital Quality Function

Geetu Abbi on When to Build a Digital Quality Function

Geetu Abbi was handed the GAMP guide as a new validation engineer at Genzyme, and in 2024 she co-led one.Geetu Abbi on When to Build a Digital Quality FunctionIn today's episode I was joined by Geetu ...

22 Sep 41min

Isha Patel on the Overnight Career Plan That Took Her from Associate Director to SVP

Isha Patel on the Overnight Career Plan That Took Her from Associate Director to SVP

Naymisha (Isha) Patel has spent thirty years in Quality and regulatory compliance across pharmaceuticals, biologics, medical devices and combination products. She is now Senior Vice President of Quali...

11 Sep 36min

Dawn Houlihan on Her Journey From Ireland Big Pharma to the Boston Start-Up World

Dawn Houlihan on Her Journey From Ireland Big Pharma to the Boston Start-Up World

Dawn Houlihan started out as the person manufacturing teams went quiet around, and spent the next twenty years proving that quality works better as a partner than a police force.Dawn Houlihan on Her J...

1 Sep 39min

Luciana Mansolelli on Her First Year as CQO in the CDMO World

Luciana Mansolelli on Her First Year as CQO in the CDMO World

Luciana Mansolelli spent twenty years on the sponsor side. One question from a board chairman moved her to a CDMO.Luciana Mansolelli on her first year as CQO in the CDMO world.In today’s episode I was...

25 Aug 39min

My Thoughts on Quality Leadership, Halfway Through Season Four

My Thoughts on Quality Leadership, Halfway Through Season Four

Season Four is at its halfway point, so instead of a guest this week I’ve gone back over the conversations so far and pulled out the theme that came up most often.The quality leader whose main functio...

30 Jul 16min

Speaking the Language of the Business, with Jamey Lindholm

Speaking the Language of the Business, with Jamey Lindholm

Quality culture isn't built by SOPs. It's built in the small moments when a leader reinforces the right behaviour or lets the wrong one slide.Speaking the Language of the Business, with Jamey Lindholm...

21 Jul 38min

The Big Pharma Habits You Have to Unlearn in a Startup, with Dawn Lundin

The Big Pharma Habits You Have to Unlearn in a Startup, with Dawn Lundin

Twenty years at Merck, then a leap into academia and psychedelic medicine - here is how Dawn Lundin built a quality career on instinct.Dawn Lundin on the big pharma habits you have to unlearn in a sta...

14 Jul 29min

How Quality Stopped Being Black and White, with Tim Mitchell

How Quality Stopped Being Black and White, with Tim Mitchell

Forty seven years in quality, and Tim Mitchell says the job he started is nothing like the one he does today.Tim Mitchell on how quality stopped being black and whiteIn today's episode I was joined by...

7 Jul 33min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
rss-pa-konto
rss-skravla-gar
pengepodden-2
livet-pa-veien-med-jan-erik-larssen
lederpodden
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
stormkast-med-valebrokk-stordalen
rss-orjasater
pengesnakk
morgenkaffen-med-finansavisen
liberal-halvtime
utbytte
okonomiamatorene
rss-markedspuls-2